Pharmacyclics Announces Oral Presentation and Material Clinical Update at the 2010 Annual Meeting of the American Society of Clinical Oncology
Title: 'Btk inhibitor PCI-32765 monotherapy induces objective responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study'
Date: Saturday, June 5, 2010,
Time: 3:45 PM Central Time
Location: Room E354a (McCormick Place) Permanent Abstract ID 8012
Primary presenter: Dr. Nathan Fowler, MD Anderson Cancer Center